Curis Balance Sheet Health
Financial Health criteria checks 6/6
Curis has a total shareholder equity of $19.7M and total debt of $42.6M, which brings its debt-to-equity ratio to 216.6%. Its total assets and total liabilities are $77.3M and $57.6M respectively.
Key information
216.6%
Debt to equity ratio
US$42.61m
Debt
| Interest coverage ratio | n/a |
| Cash | US$56.33m |
| Equity | US$19.67m |
| Total liabilities | US$57.61m |
| Total assets | US$77.28m |
Recent financial health updates
We're A Little Worried About Curis' (NASDAQ:CRIS) Cash Burn Rate
Nov 03
We're Hopeful That Curis (NASDAQ:CRIS) Will Use Its Cash Wisely
Aug 05Will Curis (NASDAQ:CRIS) Spend Its Cash Wisely?
Apr 19Is Curis (NASDAQ:CRIS) In A Good Position To Invest In Growth?
Jan 02Will Curis (NASDAQ:CRIS) Spend Its Cash Wisely?
Sep 16Recent updates
Curis, Inc. (NASDAQ:CRIS) Surges 27% Yet Its Low P/S Is No Reason For Excitement
Apr 03Curis, Inc. (NASDAQ:CRIS) Stock Catapults 63% Though Its Price And Business Still Lag The Industry
Dec 26We're A Little Worried About Curis' (NASDAQ:CRIS) Cash Burn Rate
Nov 03We're Hopeful That Curis (NASDAQ:CRIS) Will Use Its Cash Wisely
Aug 05Will Curis (NASDAQ:CRIS) Spend Its Cash Wisely?
Apr 19Is Curis (NASDAQ:CRIS) In A Good Position To Invest In Growth?
Jan 02Will Curis (NASDAQ:CRIS) Spend Its Cash Wisely?
Sep 16Curis stock soars 34% as FDA lifts partial clinical hold on emavusertib's lymphoma study
Aug 18Curis: Asymmetric Risk And Reward
Jul 17Here's Why We're Not Too Worried About Curis' (NASDAQ:CRIS) Cash Burn Situation
Mar 28Checking In On Curis
Dec 15Companies Like Curis (NASDAQ:CRIS) Can Afford To Invest In Growth
Dec 04We Think Curis (NASDAQ:CRIS) Can Afford To Drive Business Growth
Aug 29Curis Inc.: Revisiting CA-4948 After Q2 Update
Aug 25Curis, Inc. (NASDAQ:CRIS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$16.33
Mar 19Announcing: Curis (NASDAQ:CRIS) Stock Soared An Exciting 625% In The Last Year
Feb 17
Curis Inc.: Understanding CA-4948 And IRAK-4 Inhibition
Dec 23Curis prices equity offering at $5.75/share
Dec 09Curis skyrockets 141% on encouraging CA-4948 data in leukemia
Dec 08What You Need To Know About Curis, Inc.'s (NASDAQ:CRIS) Investor Composition
Dec 03Curis, National Cancer Institute in development pact for anti-cancer agent
Nov 11Financial Position Analysis
Short Term Liabilities: CRIS's short term assets ($60.9M) exceed its short term liabilities ($13.5M).
Long Term Liabilities: CRIS's short term assets ($60.9M) exceed its long term liabilities ($44.1M).
Debt to Equity History and Analysis
Debt Level: CRIS has more cash than its total debt.
Reducing Debt: CRIS had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CRIS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CRIS has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 5.8% each year.